Results 181 to 190 of about 126,042 (242)
Real-world outcome of neoadjuvant therapy with or without pembrolizumab for triple-negative breast cancer. [PDF]
Maunu M +8 more
europepmc +1 more source
ZBTB21 is a transcription factor that epigenetically suppresses pyroptosis and MHC‐I antigen presentation, enabling tumor immune evasion. Genetic ablation of ZBTB21 activates pyroptotic cell death and enhances antigen presentation, recruiting CD8+ T cells to overcome immune checkpoint blockade resistance.
Lei Zhao +12 more
wiley +1 more source
ZMIZ2/MCM3 Axis Participates in Triple-Negative Breast Cancer Progression. [PDF]
Zou X +5 more
europepmc +1 more source
A Metal‐Free Carbon Monoxide Prodrug Suppresses Metastasis of Pancreatic and Breast Cancer
A metal‐free carbon monoxide (CO) prodrug, CO‐116, delivers controlled systemic CO without inhalation. CO suppresses the HRG1–heme axis, reducing intracellular heme availability. Attenuation of this pathway inhibits metastatic progression in pancreatic and triple‐negative breast cancer models.
Tiantian Zhang +15 more
wiley +1 more source
The engineered TF‐Fe@LC nanoplatform programs paraptotic death via multipath ROS amplification that disrupts redox homeostasis, provoking mitochondrial dysfunction, autophagic blockade, and ER stress. This caspase‐independent process elicits robust immunogenic cell death, combining with αPD‐L1 to activate systemic CD8+ T‐cell immunity and suppress ...
Zhe Yu +9 more
wiley +1 more source
Management Options in Triple-Negative Breast Cancer
Christina A. Minami +2 more
doaj
Modelling the metastatic immune microenvironment in triple-negative breast cancer. [PDF]
de la Fuente LR +8 more
europepmc +1 more source

